Mirum Pharmaceuticals Inc (MIRM) stock news · rev $521.3M
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
This MIRM news page leads with what Mirum Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for MIRM yet. We will not pad this page with generic market recap.
Latest reported MIRM revenue for 2025-12-31 was $521.3M. Net income was -$23.4M. Revenue was up 54.7% from 2024-12-31 to 2025-12-31. MIRM currently screens at market cap $6.22B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MIRM stock page; for the tape open the quote page.
MIRM stock news FAQ
What are MIRM's latest revenue and net income?
Latest cached Mirum Pharmaceuticals Inc (MIRM) revenue for Dec 31, 2025 was $521.3M. Net income was -$23.4M. Statements: https://lician.com/financials/mirm
How did MIRM revenue change from the prior cached period?
Cached Mirum Pharmaceuticals Inc (MIRM) revenue was up 54.7% from $336.9M (Dec 31, 2024) to $521.3M (Dec 31, 2025). Statements: https://lician.com/financials/mirm
What is MIRM's market cap?
Mirum Pharmaceuticals Inc (MIRM) market cap is $6.22B on the latest cached fundamentals snapshot.
What kind of company is MIRM?
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Where is MIRM stock news listed?
Cached stock news for Mirum Pharmaceuticals Inc (MIRM) is listed at https://lician.com/news/mirm. Filings: https://lician.com/sec/mirm
Not investment advice.